← All trials
NCT05255848
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 20, 2022
- Primary completion
- Aug 20, 2022
- Completion date
- Oct 20, 2022
- First posted
- Feb 25, 2022
- Last posted
- Apr 26, 2022
- Enrollment
- 180
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Lady Reading Hospital, PakistanLead sponsor
- Lady Reading Hospital, PakistanReponsible party - principal investigator
- Lady Reading Hospital, PakistanSponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.